Kohlmann Grünstein Shmulevich (KGS) is a deep tech venture capital firm with offices in New York, Zurich, and Singapore. The firm partners with entrepreneurs who are looking to leverage cutting-edge, IP-centered technology to solve some of humanity's greatest challenges, including applications in neuro-tech, bioengineering, advanced materials, clean energy, and photonics. The firm is deeply embedded in global networks of next-generation entrepreneurs, VCs, industry experts, and world-leading academic institutions. With over 30 years of combined venture capital and entrepreneurship experience across multiple continents, its founders understand both sides of investing and building, creating a uniquely global and founder-support-centric firm.
Prior investments include CTRL-labs, a brain-machine-interface startup acquired by Meta (Facebook), Spiden, builder of a continuous, non-invasive biomarker monitoring platform, HyPoint, developer of high-temperature hydrogen fuel cells acquired by ZeroAvia, and Canaery, a nose-computer-interface company working on digitizing scent.
Company Details
- Founded
- -
- Address
- 3 World Trade Center, 175 Greenwich Street
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- https://kgsvc.com/
- HQ
- New York, NY
Kgs Ventures Questions
Kgs Ventures's website is https://kgsvc.com/
Kgs Ventures's LinkedIn profile is https://www.linkedin.com/company/kgsvc
Kgs Ventures's industry is
Venture Capital and Private Equity Principals
Kgs Ventures's top competitors are
Served Natural,
Tehran Ventures,
Climate First,
Kohlmann & Co Ag,
Arc Ventures,
Nextsynapse,
Threshold Neurodiagnostics,
Trinnacle Capital Management Llc,
Jumpspace Ventures,
Hof Capital.
Kgs Ventures's categories are Venture Capital and Private Equity Principals
Kgs Ventures's founding year is 2022
